Eikon Therapeutics, Inc.
Eikon Therapeutics, Inc. scores highest on Anchor (59) and lowest on Earnings (26). Its PosiPenta is 38.23 out of 100, weaker than most similar companies.
On the Penta Grid this week, Eikon Therapeutics, Inc. is Grid #598 of 837 in the Healthcare sector in United States, and Grid #3,046 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Eikon Therapeutics, Inc. | 38.23 | 41 | 26 | 37 | 29 | 59 |
| NeuroPace, Inc. | 36.12 | 1 | 62 | 61 | 16 | 41 |
| MapLight Therapeutics, Inc. | 40.66 | 37 | 33 | 16 | 52 | 65 |
| Allogene Therapeutics, Inc. | 44.32 | 39 | 42 | 31 | 48 | 62 |
| Ovid Therapeutics Inc. | 52.31 | 29 | 40 | 71 | 60 | 62 |
| ARS Pharmaceuticals, Inc. | 27.49 | 2 | 46 | 25 | 8 | 56 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -0.84 |
| P/B ratio | 0.86 |
EEarnings
| Trailing EPS | ₹-839.17 |
| Forward EPS | ₹-599.95 |
NNitro
| Price | 702.78 |
| 52-week high | 1648.04 |
| 52-week low | 610.91 |
| Fall from 52-week high | 57.4% |
TTorque
| Return on equity (ROE) | — |
| Debt-to-equity | 0.54 |
AAnchor
| Beta (price swings) | — |
| Market cap | ₹3,806 Cr |
| Insider holding | 17.38% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Eikon Therapeutics, Inc.'s PosiPenta score?
Eikon Therapeutics, Inc.'s PosiPenta is 38.23 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Eikon Therapeutics, Inc. stand on the Penta Grid?
On the Penta Grid this week, Eikon Therapeutics, Inc. is Grid #598 of 837 in the Healthcare sector in United States, and Grid #3,046 of 4,000 in United States.
Which PosiPenta pillar is strongest for Eikon Therapeutics, Inc.?
Anchor (stability and dividends), with a score of 59 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for Eikon Therapeutics, Inc.?
Earnings (growth), with a score of 26 out of 100: weaker than most similar companies.
Has Eikon Therapeutics, Inc.'s PosiPenta changed since last week?
Yes, it rose 2.73 points, from 35.50 to 38.23.
PositoAI is for research and education only and is not investment advice.